Markets
FDA declines to issue specific guidance on health programs' foreign drug imports
A CNBC investigation revealed the proliferation of AFPs, which import prescription drugs from overseas in what U.S. regulators say is a violation of import laws.
Related Articles
Markets
10 Nifty500 stocks with up to 60% upside potential; do you own any?
Several Nifty500 stocks may deliver strong returns over the next year, with analyst estimates indica...
Read More → MarketsExplained: Why RBI’s FCNR(B) and ECB swap window could be a game changer for banks
RBI’s FCNR(B) and ECB swap windows aim to boost liquidity, stabilise the rupee and ease funding co...
Read More → MarketsVedanta demerger & HFCL dip: Anand James reveals how to trade this week's top stock triggers
Also, 23700 is a stiff barrier that had troubled May for several days, and is expected to pose a sti...
Read More → MarketsCEA Anantha Nageswaran says AI stock valuations definitely in a bubble
India's Chief Economic Advisor V Anantha Nageswaran warns that artificial intelligence stock valuati...
Read More →